Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Neoplasms and RYR1[original query] |
|---|
| Germline mutations in young non-smoking women with lung adenocarcinoma. Lung cancer (Amsterdam, Netherlands) 2018 7 122 76-82. Donner Iikki, Katainen Riku, Sipilä Lauri J, Aavikko Mervi, Pukkala Eero, Aaltonen Lauri |
| Discovering novel driver mutations from pan-cancer analysis of mutational and gene expression profiles. PloS one 2020 11 15 (11): e0242780. Tegally Houriiyah, Kensler Kevin H, Mungloo-Dilmohamud Zahra, Ghoorah Anisah W, Rebbeck Timothy R, Baichoo Shakunta |
| CSMD3 is Associated with Tumor Mutation Burden and Immune Infiltration in Ovarian Cancer Patients. International journal of general medicine 2021 14 7647-7657. Lu Nan, Liu Jinhui, Xu Mengting, Liang Jianqiang, Wang Yichun, Wu Zhipeng, Xing Yan, Diao Feiya |
| The ryanodine receptor mutational characteristics and its indication for cancer prognosis. Scientific reports 2022 9 12 (1): 16113. Wang Fenglin, Yu Jingbo, Lin Ping, Sigalas Charalampos, Zhang Shibo, Gong Yuan, Sitsapesan Rebecca, Song Le |
| Ryanodine receptor (RYR) mutational status correlates with tumor mutational burden, age and smoking status and stratifies non-small cell lung cancer patient prognosis. Translational cancer research 2022 Jul 11 (7): 2070-2083. Wang Yang, Chen Yun, Zhang Libin, Xiong Jian, Xu Lele, Cheng Changfu, Xu Zheyu |
| Identification of the Immune Signatures for Ovarian Cancer Based on the Tumor Immune Microenvironment Genes. Frontiers in cell and developmental biology 2022 4 10 772701. Shen Xiaoyan, Gu Xiao, Ma Ruiqiong, Li Xiaoping, Wang Jianl |
| Identification of methyltransferase modification genes associated with prognosis and immune features of pancreatic adenocarcinoma. Molecular and cellular probes 2023 2 67 101897. Wang Wentao, Zhang Dongyuan, Chang Donglei, Li Yupeng, Ren L |
| Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance. Human genomics 2024 7 18 (1): 83. Lucie Heczko, Václav Liška, Ond?ej Vy?ítal, Ond?ej Fiala, Simona Š?sová, Viktor Hlavá?, Pavel Sou? |
| Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. The American journal of clinical nutrition 2024 7 . Elom K Aglago, Conghui Qu, Sophia Harlid, Amanda I Phipps, Robert S Steinfelder, Shuji Ogino, Claire E Thomas, Li Hsu, Amanda E Toland, Hermann Brenner, Sonja I Berndt, Daniel D Buchanan, Peter T Campbell, Yin Cao, Andrew T Chan, David A Drew, Jane C Figueiredo, Amy J French, Steven Gallinger, Peter Georgeson, Marios Giannakis, Ellen L Goode, Stephen B Gruber, Marc J Gunter, Tabitha A Harrison, Michael Hoffmeister, Wen-Yi Huang, Meredith Aj Hullar, Jeroen R Huyghe, Mark A Jenkins, Brigid M Lynch, Victor Moreno, Neil Murphy, Christina C Newton, Jonathan A Nowak, Mireia Obón-Santacana, Wei Sun, Tomotaka Ugai, Caroline Y Um, Syed H Zaidi, Konstantinos K Tsilidis, Bethany van Guelpen, Ulrike Pete |
| Tumor sequencing before and after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: Genetic tumor characterization and clinical outcome. Clinical and translational radiation oncology 2024 12 50 100894. Kerstin Clasen, Nadja Ballin, Leon Schütz, Irina Bonzheim, Olga Kelemen, Michael Orth, Cihan Gani, Olaf Rieß, Stephan Ossowski, Maximilian Niyazi, Christopher Schroed |
| Uncovering novel pathogenic variants and pathway mutations in triple-negative breast cancer among the endogamous mizo tribe. Breast cancer research and treatment 2024 10 . Lalawmpuii Pachuau, H Lalremmawia, Lalengkimi Ralte, Johan Vanlalpeka, Jeremy Lalrinsanga Pautu, Saia Chenkual, Thomas Zomuana, Sailo Tlau Lalruatfela, John Zohmingthanga, Lalchhandama Chhakchhuak, Ashok K Varma, Nachimuthu Senthil Kum |
- Page last reviewed:Feb 1, 2024
- Content source: